The novel hemoglobin-based oxygen carrier HRC 101 improves survival in murine sickle cell disease

Erythrocyte transfusion decreases morbidity in sickle cell disease, but is not without risk. Use of a hemoglobin-based oxygen carrier could offer the benefits of erythrocyte transfusion while reducing related complications. The authors tested the hypothesis that the novel hemoglobin-based oxygen car...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anesthesiology (Philadelphia) 2007-08, Vol.107 (2), p.281-287
Hauptverfasser:	CRAWFORD, Mark W, SHICHOR, Tal, ENGELHARDT, Thomas, ADAMSON, Gord, BELL, David, LOU CARMICHAEL, F. J, KIM, Peter C. W
Format:	Artikel
Sprache:	eng
Schlagworte:	Albumins - administration & dosage Anemia, Sickle Cell - drug therapy Anesthesia Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anesthetics, Inhalation - administration & dosage Animals Biological and medical sciences Blood Gas Analysis - methods Blood Substitutes - therapeutic use Disease Models, Animal Halothane - administration & dosage Heart Rate - drug effects Hemoglobins - therapeutic use Hydroxyethyl Starch Derivatives - therapeutic use Hypoxia - drug therapy Hypoxia - mortality Kaplan-Meier Estimate Lactic Acid - blood Medical sciences Mice Mice, Transgenic Oxygen - administration & dosage Oxygen - blood Survival Analysis Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!